Health News Archive - May 21, 2009
SHANGHAI, May 21 /PRNewswire/ -- Policies of the new health reform in China have been released after deep consideration and discussion, among which is one of the most important policies 'The National Essential Drug System'.
First Company to Surpass $100 Million Contribution Mark to Support Families Living with Autism and Other Disabilities CHICAGO, May 21 /PRNewswire-USNewswire/ -- Safeway (NYSE: SWY) captures Easter Seals highest honor after raising a record $10.2 million for the organizations' services for children and adults with autism and other disabilities in 2009 alone and by exceeding the $100 million milestone for lifetime contributions.
1 in 3 women opt for plastic surgery to boost confidence, whereas 1 in 3 men opt for cosmetic surgery for pure vanity - 50% of men would change nothing about their appearance - Male rhinoplasty, Botox injections and liposuction are on the rise MANCHESTER, England, May 21 /PRNewswire/ -- Both men and women are unhappy with their weight Findings from UK's biggest ever cosmetic surgery report (2000 people interviewed by GFK NOP on behalf of Transform Cosmetic Surgery Clinics) A year ago, Transform, the leading plastic surgeons in the UK, announced the results of the biggest cosmetic surgery report ever carried out.
CARLSBAD, Calif., May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral resistance, Professor Guy Boivin has used its enhanced respiratory virus panel assay to test for the presence of the new Flu A - Swine H1N1 virus.
Both Phase III pivotal trials begin enrollment in May 2009; Reinforces Lilly's commitment to Alzheimer's disease and biotech product research INDIANAPOLIS, May 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced it will begin enrolling patients this month in two separate but identical Phase III clinical trials of solanezumab(i), previously referred to as LY2062430, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
SPRING, Texas, May 21 /PRNewswire-FirstCall/ -- Go Healthy, Inc. (Pink Sheets: GOHE) announced today that the company received a letter of endorsement from District Five of the Texas Chiropractic Association. The letter, written by Dr.
State's Biggest Travel Health Firm Sees Uptick in Employer Interest in Their Niche DENVER, May 21 /PRNewswire/ -- The H1N1 flu scare has caused businesses who regularly send their employees on international business trips to "get proactive" about travel health care, according to the owner of the state's largest travel health provider. "We are hearing from more employers now about travel health issues, said Jamie Reesman, president of Passport Health Colorado.
- First-in-class treatment for inhalation anthrax - ROCKVILLE, Md., May 21 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted a Biologics License Application (BLA) to the U.S.
A California survey of people hospitalized for swine flu points to the possibility that obesity may be as serious a risk factor for health complications as diabetes, heart disease and pregnancy.
US health authorities announced on Wednesday that they may begin their annual flu vaccination campaign earlier than usual this year in order to leave time for a possible second round of shots against the new H1N1 flu strain.